Summary
A technique was developed, which made it possible to study thein vitro release of3H-acetylcholine (3H-ACh) from human post mortem brain tissue, collected with short post-mortem delay (2,5–22 hours), both from controls and patients with Alzheimer's disease (AD/SDAT). The tritium (3H) release was investigated during potassium stimulation, and AD/SDAT cortical slices were found to release a decreased amount of3H compared to control brain slices. Physostigmine, 10−5 and 10−4 M, has no significant effect on the release of3H from control slices, while physostigmine 10−4 M increased the evoked release from AD/SDAT brain slices over threefold, nearly to the control level.
Similar content being viewed by others
References
Bartus RT, Dean III RL, Beer B, Lippa AS (1982) The cholinergic hypothesis of geriatric memory dysfunction. Science 217: 408–417
Beani L, Bianchi C, Siniscalchi A, Sivilotti L, Tanganelli S, Veratti E (1984) Different approaches to study acetylcholine release: endogenous ACh versus tritium efflux. Naunyn Schmiedebergs Arch Pharmacol 328: 119–126
Beani L, Bianchi C, Nilsson L, Nordberg A, Romanelli L, Sivilotti L (1985) The effect of nicotine and cytisine on3H-acetylcholine release from cortical slices of guinea-pig brain. Naunyn Schmiedebergs Arch Pharmacol 331: 293–296
Bourdois PS, Mitchell JF, Somogyi GT, Szerb JC (1974) The output per stimulus of acetylcholine from cerebral cortical slices in the presence or absence of cholinesterase inhibition. Br J Pharmacol 52: 509–517
Briggs CA, Cooper JR (1982) Cholinergic modulation of the release of3H-acetylcholine from synaptosomes of the myenteric plexus. J Neurochem 38: 501–508
Caulfield M, Smith C (1985) British pharmacological society symposium: Alzheimer's disease-central cholinergic mechanisms. Lancet ii: 61–63
Corkin S (1981) Acetylcholine, aging and Alzheimer's disease. Trend Neuro Sci 12: 287–290
Fonnum F (1975) A rapid radiochemical method for the determination of choline acetyltransferase. J Neurochem 24: 407–409
Francis PT, Palmer AM, Sims NR, Bowen DM, Davison AN, Esiri MM, Neary D, Snowden JS, Wilcock GK (1985) Neurochemical studies of early-onset Alzheimer's disease. New Engl J Med 313: 7–11
Gottfries CG (1985) Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment. Psychopharmacology 86: 245–252
Gulaya K, Watson M, Vickoroy TM (1986) Examination of cholinergic and neuropeptide receptor alterations in Alzheimer's disease (SDAT). In: Fisher A, Hanin I, Lachman C (eds) Alzheimer's and Parkinson's disease: strategies in research and development. Advances in behavioral biology vol 29. Plenum Press, pp 109–116
Hardy JA, Adolfsson R, Alafuzoff, Bucht S, Marcusson J, Nyberg P, Perdahl E, Wester P, Winblad B (1985 a) Transmitter deficits in Alzheimer's disease. Neurochem Int 7: 545–563
Hardy JA, Bateman DE, Kidd AM, Edwardson JA, Singh GB, Dodd PR (1984) Amino acid transport by synaptosomes isolated from post mortem human brain. J Neural Transm 60: 57–62
Hardy JA, Dodd PR, Okley AE, Perry RH, Edwardson JA, Kidd AM (1983) Metabolically active synaptosomes can be prepared from frozen rat and human brain. J Neurochem 40: 608–614
Hardy JA, Wester P, Winblad B, Gezelius C, Bring G, Eriksson A (1985 b) The patients dying after long terminal phase have acidotic brains; Implications for biochemical measurements on autopsy tissue. J Neural Transm 61: 253–264
Hollander E, Mohs RC, Davies KL (1986) Cholinergic approaches to the treatment of Alzheimer's disease. Br Med Bull 42: 97–100
Johns CA, Haroutunian V, Greenwald BS, Mohs RC, Davies BM, Kanof P, Horvath TB, Davies KL (1985) Development of cholinergic drugs for the treatment of Alzheimer's disease. Drug Develop Res 5: 77–96
Mash DC, Flynn DD, Potter LT (1985) Loss of M 2 muscarine receptors in the cerebral cortex in Alzheimer's disease and experimental cholinergic denervation. Science 228: 1115–1117
McGeer PL (1984) Aging, Alzheimer's disease, and the cholinergic system. Can J Physiol Pharmacol 62: 741–754
Mohs RC, Davies BM, Mathé AA, Rosen WG, Johns CA, Greenwald BS, Horvath TB, Davies KL (1985) Intravenous and oral physostigmine in Alzheimer's disease. Interdiscipl Topics Geront 20: 140–152
Nordberg A, Larsson C, Perdahl E, Winblad B (1982) Cholinergic activity in hippocampus in chronic alcoholism. Drug and Alcohol Dependence 10: 333–344
Nordberg A, Winblad B (1986) Brain Nicotinic and Muscarinic Receptors in Normal Aging and Dementia. In: Fisher A, Hanin I, Lachman C (eds) Alzheimer's and Parkinson's disease: strategies in research and development. Advances in Behavioral Biology vol 29, Plenum Press, pp 95–108
Nordberg A, Adem A, Nilsson L, Winblad B (1986 a) Cholinergic deficits in CNS and peripheral non-neuronal tissue in Alzheimer dementia. In: Dowdell M, Hawthorne J (eds) Cellular and molecular basis of cholinergic function. Ellis-Horward, Chichester (in press)
Nordberg A, Alafuzoff I, Winblad B (1986 a) Muscarinic receptor subtypes in hippocampus in dementia of AD/SDAT and AD/MID type. Neurosci Letters (in press)
Nordberg A, Winblad B (1986) Reduced number of3H-nicotine and3H-acetylcholine binding sites in the frontal cortex of Alzheimer brains. Neurosci Letters (in press)
Nordström Ö, Bartfai T (1980) Muscarinic autoreceptor regulates acetylcholine release in the rat hippocampus:in vitro evidence. Acta Physiol 108: 347–353
Nordström Ö, Westlind A, Undén A, Meyerson B, Sachs C, Bartfai T (1982) Pre- and postsynaptic muscarinic receptors in surgical samples from human cerebral cortex. Brain res 234: 287–297
Perry EK (1986) The cholinergic hypothesis—ten years on. Br Med Bull 42: 63–69
Rylett RJ, Ball MJ, Colhoun EH (1983) Evidence for high affinity choline transport in synaptosomes prepared from hippocampus and neocortex of patients with Alzheimer's disease. Brain Res 289: 169–175
Sims NR, Smith CCT, Davison AN, Bowen DM, Flack RHA, Snowden JS (1980) Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease. Lancet i: 333–336
Stadie WC, Riggs BC (1944) Microtome for the preparation of tissue slices for metabolic studies of surviving tissuein vitro. J Biol Chem 154: 687–690
Szerb JC (1975) Endogenous acetylcholine release and labelled acetylcholine formation from3H Choline in the myenteric plexus of the guinea-pig ileum. Can J Physiol Pharmacol 53: 566–574
Szerb JC (1976) Storage and release of labelled acetylcholine in the myenteric plexus of the guinea-pig ileum. Can J Physiol Pharmacol 54: 12–22
Wikberg J (1977) Release of3H-acetylcholine from isolated guinea-pig ileum. A radiochemical method for studying the release of the cholinergic neurotransmitter in the intestine. Acta Physiol Scand 101: 302–317
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nilsson, L., Nordberg, A., Hardy, J. et al. Physostigmine restores3H-acetylcholine efflux from Alzheimer brain slices to normal level. J. Neural Transmission 67, 275–285 (1986). https://doi.org/10.1007/BF01243353
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF01243353